#DYK Primary myelofibrosis, a subtype of MPN, is a rare condition that affects approximately 1 in 500,000 people worldwide? We are committed to helping meet the needs of patients, including those with rare blood cancers, through raising awareness, education and research. This #MPNAwarenessDay, learn more about the ongoing clinical trials being done to further advance the treatment of this rare group of diseases here: https://one.bms.com/45WaXIH | Bristol Myers Squibb